Early Deregulation of Cholangiocyte NR0B2 During Primary Sclerosing Cholangitis
Background and Aims: Primary sclerosing cholangitis (PSC) is a probable autoimmune liver disease characterized by persistent and progressive biliary inflammation that leads to biliary infection, cirrhosis, or cholangiocarcinoma. Genome-wide omics data are scarce regarding this severe disease. Method...
Main Authors: | Christophe Desterke, Chuhan Chung, David Pan, Michael Trauner, Didier Samuel, Daniel Azoulay, Cyrille Feray |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-01-01
|
Series: | Gastro Hep Advances |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772572322001406 |
Similar Items
-
Non-steroidal FXR agonist cilofexor improves cholestatic liver injury in the Mdr2-/- mouse model of sclerosing cholangitis
by: Claudia D. Fuchs, et al.
Published: (2023-11-01) -
Telomere dysfunction promotes cholangiocyte senescence and biliary fibrosis in primary sclerosing cholangitis
by: Nidhi Jalan-Sakrikar, et al.
Published: (2023-10-01) -
Protective potential of the gallbladder in primary sclerosing cholangitis
by: Nora Cazzagon, et al.
Published: (2023-04-01) -
Quantitative magnetic resonance imaging for the assessment of patients with primary sclerosing cholangitis
by: Selvaraj, E
Published: (2021) -
Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis – The promise of DNA methylation and molecular biomarkersKey points
by: Hege Marie Vedeld, et al.
Published: (2020-10-01)